Fort Worth, TX, United States of America

Pete Delgado


Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1998-2010

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Inventor Pete Delgado

Introduction

Pete Delgado is a notable inventor based in Fort Worth, Texas, with a remarkable portfolio of eight patents. His work primarily focuses on the development of pharmaceutical compounds, particularly in the field of indazoles. His innovative methods have contributed significantly to the advancement of medicinal chemistry.

Latest Patents

Among his latest patents, Pete Delgado has developed methods for creating 1-alkyl-3-aminoindazoles. These methods involve reacting a 2-alkylaminobenzonitrile with a nitrosating agent, followed by a reduction-cyclization process to yield 1-alkyl-3-aminoindazoles. This compound can be further deaminated to produce 1-alkylindazoles, which are essential for synthesizing pharmaceutically active products. Additionally, he has described methods for making indazoles by reacting an aromatic aldehyde with a nitrogen source to form a nitroso aromatic aldehyde, which is then reduced to create indazoles that are also aimed at pharmaceutical applications.

Career Highlights

Throughout his career, Pete Delgado has worked with prominent companies such as Alcon, Inc. and Alcon Laboratories, Inc. His contributions to these organizations have been instrumental in advancing their research and development efforts in the pharmaceutical industry.

Collaborations

Pete has collaborated with notable colleagues, including Raymond E. Conrow and William D. Dean. Their combined expertise has fostered a productive environment for innovation and development in their respective fields.

Conclusion

Pete Delgado's contributions to the field of pharmaceutical chemistry through his innovative patents and collaborations highlight his significant impact as an inventor. His work continues to pave the way for advancements in medicinal products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…